BD Diagnostics of BD (Becton, Dickinson and Company) launches its BD Max™ open system for molecular testing in Europe for laboratories and clinicians to run BD developed assays so that they can provide enhanced testing services that recognize them as standard caring institution.  

BD Diagnostics anoounced that they received clearance form FDA for its First Fully Automated Molecular Assays for HSV1 and HSV2. After this clinicians now have a tool to help diagnose patients with Herpes Simplex Viruses (HSV1 and HSV2).